Moderna begins study of COVID-19 vaccine in kids
 
 
 
 
 
 

Moderna begins study of COVID-19 vaccine in kids

/ 07:46 AM March 16, 2021

Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday.

The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart and intends to enroll about 6,750 children in the United States and Canada.

ADVERTISEMENT

The vaccine has already been authorized for emergency use in Americans who are aged 18 and older.

In a separate study which began in December, Moderna is also testing mRNA-1273 in adolescents between 12 and 18 years old.

FEATURED STORIES

The latest study is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

U.S. drug distributors urge govt to boost COVID-19 vaccine supply network

A large vaccination site is shown as people with preexisting health conditions are granted access to a vaccination during the outbreak of the coronavirus disease (COVID-19) in Inglewood, California, U.S., March 15, 2021. REUTERS/Mike Blake

U.S. drug distributors urge govt to boost COVID-19 vaccine supply network

Three major U.S. drug distributors have requested the government to expand the COVID-19 vaccine supply chain network as the country strives to immunize its population against the novel coronavirus as quickly as possible.

AmerisourceBergen Corp, Cardinal Health Inc and Henry Schein Inc in a letter urged officials to develop a plan of action aimed at identifying ways to move the vaccines safely and quickly to administrators and vaccination sites.

The Federal Emergency Management Agency, to whom the letter was addressed, did not immediately respond to a Reuters request for comment.

The companies said on Monday the existing healthcare network, including pharmacies, doctors’ offices, hospitals and other healthcare providers, will need to be activated to achieve herd immunity against the virus.

Reuters first reported in January that Cardinal Health and AmerisourceBergen Corp were in talks with federal officials about increasing the number of companies shipping coronavirus vaccines as part of the Biden administration’s push to speed up inoculations.

ADVERTISEMENT

The U.S government in February authorized Johnson & Johnson’s single-dose COVID-19 vaccine for emergency use, making it the third vaccine to become available in the country, after those developed by Pfizer Inc and Moderna Inc received authorization late last year.

(Reporting by Amruta Khandekar; Additional reporting by Carl O’Donnell in New York; Editing by Shinjini Ganguli)

Related Articles

How to Relax With CBD

Best Gifts for Coffee Lovers

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Don't miss out on the latest news and information.
TAGS: coronavirus vaccine, Covid-19 vaccine research
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.